BVX-130-mcMMAF | m-entrepreneurship.com

Product Name :
BVX-130-mcMMAF

Search keywords :
McMMAF

drugId :
null

Target Vo:
Myeloid cell surface antigen CD33

Target Vo Short Name :
CD33

Moa_Name:
Myeloid cell surface antigen CD33 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
BiVictriX Therapeutics Ltd

Active Company_Name :
BiVictriX Therapeutics Ltd

Active Indication_Name:
Leukemia, Myeloid, Acute

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
YAP1 Rabbit mAb Technical Information
Cetuximab Autophagy
APC6 Antibody: APC6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 72 kDa, targeting to APC6. It can be used for WB,ICC/IF assays with tag free, in the background of Human, Rat.

Author: Betaine hydrochloride

Related Posts